Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

245.06
Delayed Data
As of 4:00pm ET
 +3.24 / +1.34%
Today’s Change
223.02
Today|||52-Week Range
412.24
-20.01%
Year-to-Date
The 10 Worst-Performing S&P 500 Stocks in June
Jun 30 / TheStreet.com - Paid Partner Content
Trader's Daily Notebook: If There's a Bounce, It Won't Last Long
Jun 28 / TheStreet.com - Paid Partner Content
3 Reasons To Buy Biogen
Jun 30 / MotleyFool.com - Paid Partner Content
3 Reasons Anavex Stock Could Rise
Jun 27 / MotleyFool.com - Paid Partner Content
Biogen (BIIB) Stock Up as Bernstein Initiates Coverage
Jun 29 / TheStreet.com - Paid Partner Content
A Biotech Stock Turnaround Requires an Alzheimer's Drug Miracle
Jun 27 / TheStreet.com - Paid Partner Content
These 3 Biotechs Are Down More Than 36% This Year, and They're Bargains
Jun 29 / MotleyFool.com - Paid Partner Content
Think of This Stock as Buy-ogen
Jun 25 / TheStreet.com - Paid Partner Content
Better Buy: NantKwest, Inc. vs. Ionis Pharmaceuticals
Jun 28 / MotleyFool.com - Paid Partner Content
2 Biotech Stocks That Won't Pay a Dividend Anytime Soon, and 1 That Should
Jun 24 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close241.82
Today’s open242.57
Day’s range241.59 - 246.55
Volume1,465,515
Average volume (3 months)1,813,273
Market cap$53.0B
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+11.04%
Earnings growth (next 5 years)+9.50%
Revenue growth (last year)-3.87%
P/E ratio15.1
Price/Sales7.60
Price/Book5.64

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.23+0.51%
JUNOJuno Therapeutics In...+2.25+5.85%
XONIntrexon Corp+1.76+7.15%
CTLTCatalent Inc+0.19+0.83%
Data as of 4:14pm ET, 07/01/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$4.68
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs